Course Overview

Diabetic retinopathy (DR) and diabetic macular edema (DME) pose significant threats to vision, yet routine screening remains underutilized, especially among Black and Hispanic individuals. Despite strong recommendations less than half of people with diabetes in the US undergo a dilated eye exam after being diagnosed with diabetes. Furthermore, DR/DME prevalence is significantly higher among Hispanic and Black populations, with these groups experiencing more visual impairment. By promoting routine screening for all patients with diabetes, we can mitigate the hazards of undiagnosed and untreated DR/DME. 

This on-demand video webcast aims to bridge the gap in diagnosis and reduce treatment inequities affecting minority populations. Start now to enhance vision outcomes for all patients.


Angela Elam
Angela Elam, MD, MPH

Assistant Professor
Associate Chair for Diversity, Equity, and Inclusion,
Department of Ophthalmology and Visual Sciences
University of Michigan Medical School


Paula R. Newsome
Paula R. Newsome, OD, MS, FAAO, FAAARM, CHC

Optometrist
CEO
Advantage Vision Center